START FREE TRIAL

Rogers MLSE Acquisition Tests Sports Media Ambitions

Rogers Communications (NYSE:RCI) just moved closer to full control of one of Canada’s most valuable sports platforms. The company...

Novartis’ $1.5 Billion Myricx Deal Tests Oncology Pipeline

Novartis (NYSE:NVS) has made another clear move toward oncology depth, agreeing to acquire U.K.-based Myricx Bio for up to...

Kroger’s Giant Eagle Acquisition: Scale Or Risk?

Kroger (NYSE:KR) is back in the grocery consolidation spotlight after confirming plans to acquire family-owned Giant Eagle for $1.65...

Datadog Acquisition Of Adaptive ML Could Boost AI Growth

Datadog (NASDAQ:DDOG) just made a notable AI move. On June 30, 2026, the company announced a deal to acquire...

Is WildFire The Acquisition That Expands Magnolia, Or Stretches Its Model?

Magnolia Oil & Gas Corporation (NYSE:MGY) has moved into the spotlight after reports indicated that it has become the...

Merck’s $11 BillionBio-Techne Deal Looks Strategic, But The Debt Trade-Off Is REAL

Merck KGaA (ETR:MRK) has made a bold early move under new CEO Kai Beckmann. The German drug, chemicals, and...

AbbVie’s $11 Billion Eczema Gamble Is Bigger Than Skin

AbbVie Inc. (NYSE:ABBV) may be close to buying Apogee Therapeutics for about $10.9 billion in cash. That is a...

Did Fox Pay $25 Billion For Roku’s Platform, Or Its Ad Data Edge?

Fox Corp (NASDAQ:FOXA) has made its biggest swing yet in streaming, agreeing to acquire Roku (NASDAQ:ROKU) in a cash-and-stock...

Eaton Just Made Mobility Look Smaller, But Dana May Be The REAL Test

Eaton Corporation plc (NYSE:ETN) has taken a fresh step in its portfolio reshaping. The company agreed to separate its...

Is Woodside The LNG Fix Exxon Wants, Or The RISK Investors Should Watch?

Exxon Mobil (NYSE:XOM) has reportedly been kicking the tires on possible acquisition targets, and Australia’s Woodside Energy (ASX:WDS) appears...

Did Ingredion Find A Mispriced Path Into Higher-Value Ingredients?

Ingredion (NYSE:INGR) has moved into deal mode with a recommended all-cash offer to acquire Tate & Lyle (OTC:TATYY), valuing...

Incyte Acquisition Watch: The $2 Billion Star Therapeutics Deal That Could Change Its Story

Incyte Corporation (NASDAQ:INCY) is back in the biotech deal spotlight. The company is reportedly nearing an agreement to acquire...